165 related articles for article (PubMed ID: 19012859)
1. Off-label use of anticancer drugs.
Levêque D
Lancet Oncol; 2008 Nov; 9(11):1102-7. PubMed ID: 19012859
[TBL] [Abstract][Full Text] [Related]
2. [Off label drug use in adult patients treated by anticancer chemotherapy].
Levêque D; Michallat AC; Schaller C; Ranc M
Bull Cancer; 2005 May; 92(5):498-500. PubMed ID: 15932813
[TBL] [Abstract][Full Text] [Related]
3. Off-label use of anti-cancer drugs in India: to be or not to be!
Gota V; Patial P
J Cancer Res Ther; 2011; 7(1):35-9. PubMed ID: 21546740
[TBL] [Abstract][Full Text] [Related]
4. Reimbursement for cancer treatment: coverage of off-label drug indications.
American Society of Clinical Oncology
J Clin Oncol; 2006 Jul; 24(19):3206-8. PubMed ID: 16717290
[TBL] [Abstract][Full Text] [Related]
5. [Anticancer drugs off label used of: what do the experts think about?].
Debrix I; André T; Becker A; Lotz JP; Gligorov J; Boukari Y; Milleron B; Pene F; Flahault A
Bull Cancer; 2004 Oct; 91(10):769-77. PubMed ID: 15556877
[TBL] [Abstract][Full Text] [Related]
6. [Anticancer drugs use evaluation: limits of the approved labeling].
Debrix I; André T; Flahault A; Kalu O; Gligorov J; Lotz JP; Milleron B; Pene F; Boukari Y; Becker A
Bull Cancer; 2004 May; 91(5):437-43. PubMed ID: 15281283
[TBL] [Abstract][Full Text] [Related]
7. Access to anticancer drugs: many evidence-based treatments are off-label and unfunded by the Pharmaceutical Benefits Scheme.
Mellor JD; Van Koeverden P; Yip SW; Thakerar A; Kirsa SW; Michael M
Intern Med J; 2012 Nov; 42(11):1224-9. PubMed ID: 22372936
[TBL] [Abstract][Full Text] [Related]
8. Reimbursement policies constrain the practice of oncology.
Laetz T; Silberman G
JAMA; 1991 Dec; 266(21):2996-9. PubMed ID: 1820471
[TBL] [Abstract][Full Text] [Related]
9. Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
Kocs D; Fendrick AM
Am J Manag Care; 2003 May; 9(5):393-400; quiz 401-2. PubMed ID: 12744301
[TBL] [Abstract][Full Text] [Related]
10. Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs.
Herbrand AK; Schmitt AM; Briel M; Ewald H; Goldkuhle M; Diem S; Hoogkamer A; Joerger M; Moffa G; Novak U; Hemkens LG; Kasenda B
JAMA Netw Open; 2021 Mar; 4(3):e210380. PubMed ID: 33651108
[TBL] [Abstract][Full Text] [Related]
11. FDA proposes new rules for off-label use of prescription drugs. Food and Drug Administration.
Baker R
BETA; 1998 Jul; ():8-9. PubMed ID: 11365570
[TBL] [Abstract][Full Text] [Related]
12. Satisfaction with pharmacotherapy for approved and off-label indications--a Delphi study.
Kos M; Wertheimer AI; Mrhar A
Ann Pharmacother; 2005 Apr; 39(4):649-54. PubMed ID: 15755789
[TBL] [Abstract][Full Text] [Related]
13. [Assessment off-label prescribing in Dermatology].
Picard D; Carvalho P; Bonnavia C; Louin L; Josset V; Lauret P; Joly P;
Ann Dermatol Venereol; 2003 May; 130(5):507-10. PubMed ID: 12843825
[TBL] [Abstract][Full Text] [Related]
14. Antineoplastic agents: comparing off-label uses among authoritative drug compendia.
Thompson DF; Keefe CC
Hosp Formul; 1993 Jul; 28(7):641-2, 647. PubMed ID: 10127046
[TBL] [Abstract][Full Text] [Related]
15. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
[TBL] [Abstract][Full Text] [Related]
16. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
17. Reflections about off-label use of anticancer drugs.
Tartarone A; Lerose R; Aieta M
Ther Drug Monit; 2012 Oct; 34(5):604. PubMed ID: 22972541
[No Abstract] [Full Text] [Related]
18. [Off-label use: update and relevance for urology].
Krege S; Rohde D
Aktuelle Urol; 2007 Jul; 38(4):301-4. PubMed ID: 17647167
[TBL] [Abstract][Full Text] [Related]
19. [Off-label use in oncology. Quackery or progress?].
Rebscher H
MMW Fortschr Med; 2002 Oct; 144(41):25-6. PubMed ID: 12593414
[No Abstract] [Full Text] [Related]
20. [Off-label therapies in oncology].
Telekes A
Orv Hetil; 2009 Feb; 150(8):363-72. PubMed ID: 19218146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
